Alcyone Therapeutics: Funding, Investors & Team (Sep 2026)
Alcyone Therapeutics is leading the way in developing advanced precision genetic therapies for the central nervous system, aiming to uncover new opportunities and conquer obstacles in the field of CNS therapy.
Alcyone Therapeutics has raised $23.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2025.
Alcyone Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Alcyone Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Alcyone Therapeutics raised $23.0M in an undisclosed round announced in Jun 2021.
3.8 years later, an undisclosed round was announced in Apr 2025 with no disclosed amount.
Alcyone Therapeutics Founders and Leadership Team
Contact details for the Alcyone Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Alcyone Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Alcyone Therapeutics in Biotechnology and Lowell
Companies Similar to Alcyone Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Alcyone Therapeutics Funding FAQs
What does Alcyone Therapeutics do?
Alcyone Therapeutics is leading the way in developing advanced precision genetic therapies for the central nervous system, aiming to uncover new opportunities and conquer obstacles in the field of CNS therapy.
How much funding has Alcyone Therapeutics raised?
Alcyone Therapeutics has raised $23.0M across 2 rounds on record.
When did Alcyone Therapeutics last raise funding?
Alcyone Therapeutics' most recent funding round on record was announced in Apr 2025. The amount was not disclosed.
Who founded Alcyone Therapeutics?
FundedIQ lists Pj Anand (Founder) at Alcyone Therapeutics.
Where is Alcyone Therapeutics headquartered?
Alcyone Therapeutics is based in Lowell, Massachusetts, United States.
How many employees does Alcyone Therapeutics have?
Alcyone Therapeutics is in the 11-50 employee band.
About FundedIQ's Alcyone Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alcyone Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.